EMCDDA Report - Responding to new psychoactive substances

This briefing paper from the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) describes some of the practical and legal obstacles facing Member States when responding to such new substances.

The paper underlines the importance of national early-warning systems in detecting and identifying new substances as the first step towards assessing the risks of, and ultimately controlling, potentially dangerous new drugs.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.